Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 CT to Evaluate the Safety and Efficacy of Topical Administration of Bacteriophage Therapy TP-102 in Patients With DFI

NCT05948592 is registered in ClinicalTrials.gov with Technophage, SA as lead sponsor.

NCT NCT05948592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05948592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 CT to Evaluate the Safety and Efficacy of Topical Administration of Bacteriophage Therapy TP-102 in Patients With DFI
Lead sponsor
Technophage, SA
Phase
Phase 2
Overall status
Completed
Start date
November 8, 2023
Completion date
December 19, 2025
Enrollment
76 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot infection